New wearable pump could send heart failure patients home early
NCT ID NCT05419115
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This phase 2 trial tested whether a new wearable pump that delivers a water pill (furosemide) under the skin could help heart failure patients leave the hospital earlier. 172 adults admitted for heart failure were randomly assigned to either go home with the pump or stay in the hospital for standard IV treatment. The main goal was to see if the home group spent more days alive and out of the hospital within 30 days.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- furosemide (a water pill) given under the skin via a wearable pump
- What this could lead to
- If it works, this could allow heart failure patients to finish their treatment at home instead of in the hospital, improving comfort and freeing up hospital beds.
- What could go wrong
- This is a small, early-phase trial (172 people) testing a new device and drug formulation. The device is not yet approved, and the approach may not prove safe or effective enough for routine use.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Basildon University Hospital
Basildon, England, SS16 5NL, United Kingdom
-
Blackpool Victoria Hospital
Blackpool, England, FY3 8NR, United Kingdom
-
Forth Valley Hospital
Larbert, Scotland, FK5 4WR, United Kingdom
-
Glasgow Royal Infirmary
Glasgow, Scotland, G12 8TA, United Kingdom
-
Glenfield Hospital
Leicester, England, LE3 9QP, United Kingdom
-
Leeds General Infirmary
Leeds, England, LS1 3EX, United Kingdom
-
Manchester Heart Centre
Manchester, England, M13 9WL, United Kingdom
-
Ninewells Hospital
Dundee, Scotland, DD1 9SY, United Kingdom
-
Queen Alexandra Hospital
Portsmouth, England, PO6 3LY, United Kingdom
-
Queen Elizabeth University Hospital
Glasgow, Strathclyde, G51 4TF, United Kingdom
-
Southmead Hospital
Bristol, England, BS10 5NB, United Kingdom
-
St Thomas' Hospital
London, England, SE1 7EH, United Kingdom
-
St. George's University of London
London, England, SW17 0RE, United Kingdom
-
Stoke Mandeville Hospital
Aylesbury, England, HP21 8AL, United Kingdom
-
Sunderland Royal Hospital
Sunderland, England, SR4 7TP, United Kingdom
-
The Great Western Hospital
Swindon, United Kingdom, SN3 6BB, United Kingdom
-
University Hospital Ayr
Ayr, Scotland, KA6 6DX, United Kingdom
-
University Hospital Monklands
Airdrie, ML6 0JS, United Kingdom
-
University Hospital Southampton
Southampton, United Kingdom
-
University Hospital of North Tees
Hardwick, England, TS19 8PE, United Kingdom
-
University Hospitals Dorset
Bournemouth, England, BH7 7DW, United Kingdom
-
Wycombe General Hospital
High Wycombe, England, HP11 2TT, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could delaying kidney implant during heart transplant reduce complications?
- A simple conversation could change how heart failure patients care for themselves
- A picture-based lesson may help heart failure patients spot trouble early
- Can a Two-Drug punch early in hospitalization tame heart failure?
- Bedside flu shot for heart patients: a simple strategy to save lives?
- AI takes on sonographers: a 4,000-Patient trial to sharpen heart imaging